The last clinical trial update that RCPI released for the UK trial says that besides identifying an optimal formulation, “Exploratory pharmacodynamic (PD) outcome measures are also being assessed.”
Institutional ownership has risen from near zero to over 18% by the end of last quarter.
That 18% was adjusted to the new share count after the registered direct offering.
But you knew that didn't you twicey.
But everyone knows you try to spin LIES
“Part One of the Phase I study is complete.”
The company has already said there were no safety issues associated with part one but the company needs to issue a more detailed update as soon as possible. Otherwise, the naked shorts will continue to leverage the silence.
Despite the shorts posting that RCPI has no money for clinical trials, I believe Part 2 of the Phase 1 trial is currently underway.
You said you used to be a shareholder.
Which means you would have received a settlement form.
Look in the mirror and ask Joe
I don't think this new crop of shorts understand that a big part of the EU trial currently underway is to OPTIMIZE a time release formulation.
1) Demonstrates a process used to measure anti-inflammatory response
2) The results were positive
3) The process can be used to OPTIMIZE a time release formulation in EU trial
4) The results can be used to help attract development PARTNERS.
That is just four reasons why the NZ trial is important, and there is more,
which the Shorts won't like
The shorts are worried that the rise today will attract attention,
so the posting of LIES is rapidly increasing.
The shorts just can't accept the reality that the Clinical Trial in Europe just keeps marching forward.
Prescription NSAID labels now will alert consumers that the higher risk of stroke or heart attack is evident in the first weeks a patient starts taking such drugs, that the risk appears to escalate at higher doses and with longer use, and that even people with no other cardiovascular risk factors are more likely to suffer heart attack or stroke when taking the medications.
The warnings will also note for the first time that using NSAIDs increases a person's likelihood of suffering heart failure and that in their first year after a heart attack, patients treated with such medications were more likely to die than heart attack victims who did not take them.
Google - FDA strengthens warning on prescription anti-inflammatory medications
looks like the Obuma FDA is eating crow tonight
The shorts don't want longs to read the National Center for Biotechnology Information (NCBI) article on STAT3 and NF-kB collaboration and crosstalk in cancer?
After you read that article, in combination with the NZ trial press release,
you will UNDERSTAND why the shorts don't want anyone reading that article.
That explains why Joe/Drum can't let go of JW.
JW is gone but just like a vindictive gilt'ed girlfriend
joe/drum can't let go.